197 related articles for article (PubMed ID: 24517870)
1. TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).
Uno H; Kabashima K; Tohyama M; Watanabe T; Hashimoto K; Iijima M; Sueki H; Watanabe H
J Dermatol Sci; 2014 May; 74(2):177-9. PubMed ID: 24517870
[No Abstract] [Full Text] [Related]
2. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
Kamijima M; Wang H; Yamanoshita O; Ito Y; Xia L; Yanagiba Y; Chen C; Okamura A; Huang Z; Qiu X; Song X; Cai T; Liu L; Ge Y; Deng Y; Naito H; Yoshikawa T; Tohyama M; Li L; Huang H; Nakajima T
J Dermatol Sci; 2013 Dec; 72(3):218-24. PubMed ID: 23928230
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS).
Ogawa K; Morito H; Hasegawa A; Miyagawa F; Kobayashi N; Watanabe H; Sueki H; Tohyama M; Hashimoto K; Kano Y; Shiohara T; Ito K; Fujita H; Aihara M; Asada H
Br J Dermatol; 2014 Aug; 171(2):425-7. PubMed ID: 24601914
[No Abstract] [Full Text] [Related]
4. Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Watanabe H
J Immunol Res; 2018; 2018():5163129. PubMed ID: 29744372
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic.
Johnson S; Mathews S; Hudnall SD
Histopathology; 2017 Jun; 70(7):1166-1170. PubMed ID: 28008656
[TBL] [Abstract][Full Text] [Related]
6. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
Tohyama M; Hashimoto K; Yasukawa M; Kimura H; Horikawa T; Nakajima K; Urano Y; Matsumoto K; Iijima M; Shear NH
Br J Dermatol; 2007 Nov; 157(5):934-40. PubMed ID: 17854362
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution.
Ushigome Y; Kano Y; Ishida T; Hirahara K; Shiohara T
J Am Acad Dermatol; 2013 May; 68(5):721-8. PubMed ID: 23182063
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
9. Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).
Miyagawa F; Nakamura Y; Miyashita K; Iioka H; Himuro Y; Ogawa K; Nishimura C; Nishikawa M; Mitsui Y; Ito Y; Ommori R; Mori Y; Asada H
J Dermatol Sci; 2016 Aug; 83(2):151-4. PubMed ID: 27174092
[No Abstract] [Full Text] [Related]
10. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
11. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
Kano Y; Shiohara T
Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
[TBL] [Abstract][Full Text] [Related]
12. Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: a case report.
Mine S; Suzuki K; Sato Y; Fukumoto H; Kataoka M; Inoue N; Ohbayashi C; Hasegawa H; Sata T; Fukayama M; Katano H
J Clin Virol; 2014 Nov; 61(3):448-52. PubMed ID: 25249343
[TBL] [Abstract][Full Text] [Related]
13. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
14. Facial paralysis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) with oxcarbazepine and reactivation of human herpesvirus 6 (HHV-6).
Kluger N; Descamps V; Lappalainen K; Roivainen R
Int J Dermatol; 2020 Apr; 59(4):e114-e115. PubMed ID: 31840232
[No Abstract] [Full Text] [Related]
15. Involvement of Human Herpesvirus 6 Infection in Renal Dysfunction Associated with DIHS/DRESS.
Miyashita K; Shobatake C; Miyagawa F; Kobayashi N; Onmori R; Yonekawa S; Tanabe K; Kawate K; Morita K; Asada H
Acta Derm Venereol; 2016 Jan; 96(1):114-5. PubMed ID: 26039936
[No Abstract] [Full Text] [Related]
16. [Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation].
Funck-Brentano E; Duong T; Family D; Bouaziz JD; Ortonne N; Bagot M; Roujeau JC; Wolkenstein P; Valeyrie-Allanore L
Ann Dermatol Venereol; 2011; 138(8-9):580-5. PubMed ID: 21893231
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Hagiya H; Iwamuro M; Tanaka T; Hasegawa K; Hanayama Y; Kimura M; Otsuka F
Intern Med; 2016; 55(13):1769-74. PubMed ID: 27374681
[TBL] [Abstract][Full Text] [Related]
18. Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivation.
Ferrero NA; Pearson KC; Zedek DC; Morrell DS
Pediatr Dermatol; 2013; 30(5):608-13. PubMed ID: 24016284
[TBL] [Abstract][Full Text] [Related]
19. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome.
Kano Y; Inaoka M; Sakuma K; Shiohara T
Toxicology; 2005 Apr; 209(2):165-7. PubMed ID: 15767030
[TBL] [Abstract][Full Text] [Related]
20. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS) caused by levofloxacin in a patient with systemic scleroderma, rheumatoid arthritis, and Sjogren syndrome.
Matsumoto T; Horino T; Inotani S; Ichii O; Terada Y
Contact Dermatitis; 2019 Apr; 80(4):253-254. PubMed ID: 30484869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
